About RxCelerate
RxCelerate is a company based in Babraham (United Kingdom) founded in 2012.. RxCelerate has completed 5 acquisitions, including Methuselah Health, Prosarix and The Cambridge Partnership. RxCelerate offers products and services including In Silico Drug Design, Antibody Discovery Platform, and Proteomics Platform. RxCelerate operates in a competitive market with competitors including Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others.
- Headquarter Babraham, United Kingdom
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rxcelerate Limited
- Date of Incorporation 07 Nov, 2012
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
-
Investments & Acquisitions
Methuselah Health
& 4 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RxCelerate
RxCelerate offers a comprehensive portfolio of products and services, including In Silico Drug Design, Antibody Discovery Platform, and Proteomics Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Computational platform for designing small molecule drugs.
Service for rapid identification of antibody leads.
Tool for protein analysis in drug development.
Unlock access to complete
Funding Insights of RxCelerate
- Total Funding Total Funding
- Total Rounds 1
- Last Round Last Round
- First Round First Round
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2024 | Amount | Seed - RxCelerate | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by RxCelerate
RxCelerate has strategically engaged in corporate development activities, having acquired 5 companies. Notable acquisitions include Methuselah Health, Prosarix and The Cambridge Partnership. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Novel targets for aging-related diseases are developed via proteome research.
|
2015 | ||||
|
Infrastructure and management services for virtual biotech companies are provided.
|
2013 | ||||
|
Inspirational teachers and future school leaders are provided to schools.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - RxCelerate
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rxcelerate Comparisons
Competitors of RxCelerate
RxCelerate operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Gentronix, Tigermed, Shanghai Yaocheng Health Technology, ReveraGen and Aquila BioMedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In-vitro and in-vivo genetic toxicology screening services are provided.
|
|
| domain | founded_year | HQ Location |
Drug development and preclinical services are provided by Tigermed.
|
|
| domain | founded_year | HQ Location |
Clinical trial services to biopharma sector are provided.
|
|
| domain | founded_year | HQ Location |
Steroids for Duchenne muscular dystrophy treatment are developed.
|
|
| domain | founded_year | HQ Location |
Preclinical services in immunology, regeneration, neuroscience, and histology are provided.
|
|
| domain | founded_year | HQ Location |
Contract research on infectious disease models is conducted.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Rxcelerate
Frequently Asked Questions about RxCelerate
When was RxCelerate founded?
RxCelerate was founded in 2012 and raised its 1st funding round 12 years after it was founded.
Where is RxCelerate located?
RxCelerate is headquartered in Babraham, United Kingdom. It is registered at Babraham, Cambridgeshire, United Kingdom.
What does RxCelerate do?
Founded in 2012 and based in Babraham, United Kingdom, RxCelerate operates in the biotechnology sector. Pre-clinical contract research services are provided to advance lead candidates from discovery to IND readiness. Key offerings include GLP efficacy studies, toxicology assessments, and ADME evaluations, supporting pharmaceutical development processes.
Who are the top competitors of RxCelerate?
What products or services does RxCelerate offer?
RxCelerate offers In Silico Drug Design, Antibody Discovery Platform, and Proteomics Platform.
How many acquisitions has RxCelerate made?
RxCelerate has made 5 acquisitions, including Methuselah Health, Prosarix, and The Cambridge Partnership.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.